AlphaFold

AlphaFold, developed by DeepMind, represents one of the most transformative AI breakthroughs in modern science. It predicts 3D protein structures from amino acid sequences with remarkable accuracy, effectively solving a 50-year grand challenge in biology. The AlphaFold Protein Structure Database, hosted by EMBL-EBI, now contains over 200 million predicted structures"covering nearly every known protein"all freely accessible.

Strengths are numerous: it's completely free and open source, offers API access for programmatic queries, and integrates seamlessly into existing research workflows. The accuracy rivals experimental methods like X-ray crystallography for many proteins, dramatically accelerating research timelines from months to minutes.

For drug discovery, AlphaFold is a game-changer, enabling researchers to understand target protein structures without costly lab work. Its impact on healthcare research, from understanding disease mechanisms to designing therapeutics, is already profound.

Limitations include reduced accuracy for intrinsically disordered regions, protein complexes, and conformational dynamics. It predicts static structures rather than dynamic behavior. Despite these caveats, AlphaFold remains an indispensable tool that has fundamentally reshaped structural biology and computational drug design.